Advertisement

Topics

Monster Digital and Innovate Biopharmaceuticals Sign Merger Agreement

09:00 EDT 3 Jul 2017 | BioMedReports - Blog

Effects a public listing of an autoimmune biotechnology company with its first drug expected to enter Phase 3 trials in late 2017 for celiac disease

Read more...

Original Article: Monster Digital and Innovate Biopharmaceuticals Sign Merger Agreement

NEXT ARTICLE

More From BioPortfolio on "Monster Digital and Innovate Biopharmaceuticals Sign Merger Agreement"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...